Form 4 for MGNX MACROGENICS INC
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001125345-24-000055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-04 | MGNX | Spitznagel Thomas | SVP, Technical Ops | M - OptEx | $11.50 | +10.0K | 18.3K | +120% | +$115.0K |
| D | 2024-03-06 | 2024-03-04 | MGNX | Spitznagel Thomas | SVP, Technical Ops | S - Sale+OE | $20.00 | -10.0K | 8,316 | -55% | -$200.0K |
| D | 2024-03-06 | 2024-03-04 | MGNX | Spitznagel Thomas | SVP, Technical Ops | M - OptEx | $0.00 | -10.0K | 77.0K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | M | A | 10,000 | $11.50 | 18,316 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-04 | S | D | 10,000 | $20.00 | 8,316 | D | — | — | |
| 3 | Derivative | Employee stock option (right to buy) | 2024-03-04 | M | D | 10,000 | $0.00 | 77,000 | D | $11.50 · — to 2030-02-20 | 10,000 Common Stock | (F2) 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |